Dipivefrin
Back to searchMolecule Structure
Scientific Name
Dipivefrin
Description of the Drug
Dipivefrin is a prodrug of epinephrine used in ophthalmic solutions to reduce intraocular pressure in chronic open-angle glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00449
http://www.drugbank.ca/drugs/DB00449
Brand Name(s)
Not Available
Company Owner(s)
Allergan Pharmaceutical, Bausch And Lomb Pharmaceuticals Inc, Falcon Pharmaceuticals Ltd, Akorn Operating Co Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Adrenergic receptor | PROTEIN FAMILY | AGONIST | CHEMBL2331074 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL24713 | |
PharmGKB | PA449364 | |
Human Metabolome Database | HMDB0014592 | |
DrugBank | DB00449 | |
PubChem: Thomson Pharma | 14900877 | |
PubChem | 3105 | |
LINCS | LSM-1583 | |
Nikkaji | J2.819.745D | |
EPA CompTox Dashboard | DTXSID1048544 | |
DrugCentral | 922 | |
ChemicalBook | CB6676807 | |
Guide to Pharmacology | 7166 | |
rxnorm | DIPIVEFRIN HYDROCHLORIDE | DIPIVEFRIN |
KEGG Ligand | C06963 | |
ChEBI | 4646 |